Patients with COVID-19 who required intensive care unit (ICU) treatment exhibited higher levels of Th17 cells and more severe clinical symptoms compared to those not in the ICU, likely due to the overproduction of IL-17 and related cytokines [31]. This evidence concerns the gene IL17A and COVID-19.